RTW Biotech Opportunities - executive interview
Executive interview
22 January 2024
Edison’s head of investment companies, Rob Murphy, met Roderick Wong, managing director of RTW Investments, to discuss RTW Biotech Opportunities (RTW Bio; ticker RTW/RTWG). Wong outlines RTW Bio’s outperformance versus its two biotech index benchmarks in 2023 and since the fund’s launch in October 2019. He also discusses his outlook for the biotech industry in 2024. Furthermore, Wong highlights RTW Bio’s acquisition of Arix Bioscience’s assets and the anticipated timeline for the deal to be completed. Finally, Wong reiterates his vision for RTW Bio and how it fits in with RTW Investments' other funds. MORE »
